BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Jul 5, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-07-02

Reporting Person: Mueller Brian (VP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-02	Common Stock	M	2770	$17.86	Acquired	18110	Direct
2012-07-02	Common Stock	S	2770	$40.00	Disposed	15340	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-02	Stock Option (right to buy) Common Stock	$17.86	M	2770	Disposed	2018-12-16	Common Stock (2770)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 8, 2012.

F2: Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.